Display options
Cite
González-Cuesta M, Sidhu P, Ashmus RA, et al. Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications. J Am Chem Soc. 2022;doi: 10.1021/jacs.1c10504.
González-Cuesta, M., Sidhu, P., Ashmus, R. A., Males, A., Proceviat, C., Madden, Z., Rogalski, J. C., Busmann, J. A., Foster, L. J., García Fernández, J. M., Davies, G. J., Ortiz Mellet, C., & Vocadlo, D. J. (2022). Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications. Journal of the American Chemical Society, . https://doi.org/10.1021/jacs.1c10504
González-Cuesta, Manuel, et al. "Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications." Journal of the American Chemical Society vol. (2022). doi: https://doi.org/10.1021/jacs.1c10504
González-Cuesta M, Sidhu P, Ashmus RA, Males A, Proceviat C, Madden Z, Rogalski JC, Busmann JA, Foster LJ, García Fernández JM, Davies GJ, Ortiz Mellet C, Vocadlo DJ. Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications. J Am Chem Soc. 2022 Jan 05; doi: 10.1021/jacs.1c10504. Epub 2022 Jan 05. PMID: 34985906.
Copy Download .nbib Format: NLM
Share it on

J Am Chem Soc. 2022 Jan 05; doi: 10.1021/jacs.1c10504. Epub 2022 Jan 05.

Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications.

Journal of the American Chemical Society

Manuel González-Cuesta, Peter Sidhu, Roger A Ashmus, Alexandra Males, Cameron Proceviat, Zarina Madden, Jason C Rogalski, Jil A Busmann, Leonard J Foster, José M García Fernández, Gideon J Davies, Carmen Ortiz Mellet, David J Vocadlo

Affiliations

  1. Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, 41012 Sevilla, Spain.
  2. Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.
  3. Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada.
  4. Department of Chemistry. University of York, York YO10 5DD, United Kingdom.
  5. Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.
  6. Instituto de Investigaciones Químicas (IIQ), CSIC, Universidad de Sevilla, 41092 Sevilla, Spain.

PMID: 34985906 DOI: 10.1021/jacs.1c10504

Abstract

Owing to its roles in human health and disease, the modification of nuclear, cytoplasmic, and mitochondrial proteins with O-linked

Publication Types